
About VHB Life Sciences
VHB Life Sciences is a Healthcare company based in Mumbai (India) founded in 1946. Generics and APIs are manufactured across therapeutic segments. The company has 280 employees. Its Indian entity Vhb Medi Sciences Limited reported revenue of βΉ159 Cr. VHB Life Sciences offers products and services including Anti-Cancer Drugs, Anti-Infective Drugs, General Injectables, and Hormones. Its focus areas include Diversified Pharmaceuticals.
Company details
VHB Life Sciences was founded in 1946 and is headquartered in Mumbai, India. Operations focus on the pharmaceutical sector, where branded generics and active pharmaceutical ingredients are produced and marketed. Coverage includes multiple therapeutic areas such as cardiology, immunology, oncology, neurology, nephrology, gynecology, and paediatric care. The company serves domestic and international markets through its manufacturing facilities.
- Headquarters Mumbai, India
- Employees 280
- SectorsHealthcare
- Phoneβ’β’β’β’ β’β’β’β’
- Website vhbgroup.com
- Social LinkedIn Facebook
- Legal Name Vhb Medi Sciences Limited
- Date of Incorporation 12 Sep, 2007
- Jurisdiction Kandivlai West, Maharashtra, India
- Annual Revenue₹159 Cr
FY 2025 · +14% YoY
- Net Profit₹11.97 Cr
FY 2025 · 8% margin
- EBITDA₹23.13 Cr
FY 2025 · 15% margin
- Employee Count280
Associated legal entities of VHB Life Sciences
VHB Life Sciences is associated with 2 registered companies on The Company Check; the primary company is Vhb Medi Sciences Limited. Each company page carries the filings, financials, charges and directors of that entity.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Vhb Medi Sciences Limited CIN U24232MH2007PLC174054 | Active | 12 Sep 2007 | Kandivlai West, Maharashtra | ₹159 Cr | 280 | 5 | View details |
| Vhb Life Sciences Limited CIN U74900MH2007PLC171648 | Active | 13 Jun 2007 | Kandivlai West, Maharashtra | ₹14.0 Cr | 86 | 5 | View details |
Products & Services of VHB Life Sciences
VHB Life Sciences offers a comprehensive portfolio of products and services, including Anti-Cancer Drugs, Anti-Infective Drugs, General Injectables, and Hormones.
Treatments for cancer and related conditions
Medications to combat bacterial and viral infections
Injectable formulations for various medical applications
Hormonal treatments for endocrine and related disorders
Board of directors of Vhb Medi Sciences Limited (VHB Life Sciences)
Vhb Medi Sciences Limited is the primary company behind VHB Life Sciences. The boards of the 2 registered companies of VHB Life Sciences currently have 4 directors; the longest-serving is Rahul Ashokkumar Jain, appointed in 2012. 23 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Rahul Ashokkumar Jain DIN 01304110 | Director | 27 Sep 2012 | 14 yrs 1 mo | Vhb Medi Sciences Limited, Vhb Life Sciences Limited |
| Uttamchand Kesharimal Jain DIN 00205866 | Director | 27 Sep 2012 | 14 yrs 1 mo | Vhb Medi Sciences Limited, Vhb Life Sciences Limited |
| Ashokkumar Keshrimal Jain DIN 00205810 | Whole-time director | 27 Sep 2012 | 14 yrs 1 mo | Vhb Medi Sciences Limited, Vhb Life Sciences Limited |
| Pravin Keshrimal Jain DIN 00205927 | Director | 27 Sep 2012 | 14 yrs 1 mo | Vhb Medi Sciences Limited, Vhb Life Sciences Limited |
People of VHB Life Sciences
1 people are tracked at VHB Life Sciences (1 in leadership); the tracked headcount is 280.
| Name | Role | Group |
|---|---|---|
Ashok Keshrimal Jain | Director | Leadership |
Complete people profiles for VHB Life Sciences
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Financials of VHB Life Sciences
Figures of Vhb Medi Sciences Limited, the primary company behind VHB Life Sciences, for FY 2025. Revenue was ₹159 Cr (+14% year on year). Net profit was ₹11.97 Cr (8% margin). EBITDA was ₹23.13 Cr (15% margin). Revenue has grown at a compounded annual rate of +5% over three years and +10% over five years.
- ₹159 CrRevenue · FY 2025 · +14% YoY
- ₹11.97 CrNet profit · 8% margin
- ₹23.13 CrEBITDA · 15% margin
- ₹12.75 CrPaid-up capital
- 280Employees (provident fund records)
- +5%Revenue CAGR, 3 years
- +10%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Vhb Medi Sciences Limited are on its company page.
Detailed financial statements for VHB Life Sciences
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about VHB Life Sciences
VHB Life Sciences was founded in 1946.
VHB Life Sciences is headquartered in Mumbai, India. It is registered at Mumbai, Maharashtra, India.
VHB Life Sciences has 280 employees.
The primary company behind VHB Life Sciences, Vhb Medi Sciences Limited, reported revenue of βΉ159 Cr for FY 2025, up 14% year on year.
VHB Life Sciences was founded in 1946 and is headquartered in Mumbai, India. Operations focus on the pharmaceutical sector, where branded generics and active pharmaceutical ingredients are produced and marketed. Coverage includes multiple therapeutic areas such as cardiology, immunology, oncology, neurology, nephrology, gynecology, and paediatric care. The company serves domestic and international markets through its manufacturing facilities.
VHB Life Sciences offers Anti-Cancer Drugs, Anti-Infective Drugs, General Injectables, and Hormones.
VHB Life Sciences is associated with 2 legal entities: Vhb Medi Sciences Limited, Vhb Life Sciences Limited.
The legal entities of VHB Life Sciences currently have 7 directors, including Rohan Jain Ashok, Rahul Ashokkumar Jain, Uttamchand Kesharimal Jain and others.